Epidemiology of Human Fascioliasis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Fasciola Hepatica: a Review of the Economic Impact in Cattle and Considerations for Control
Veterinary Therapeutics • Vol. 2, No. 1, Winter 2001 Fasciola hepatica: A Review of the Economic Impact in Cattle and Considerations for Control Ray M. Kaplan, DVM, PhD Department of Medical Microbiology and Parasitology College of Veterinary Medicine University of Georgia Athens, Georgia 30602 I ABSTRACT opportunity to administer strategic treatments To understand the rationale behind recom- and still receive meaningful benefit is fairly mended control programs for liver flukes in large. To properly understand the rationale be- cattle, the economic impact and the complex hind recommended control programs, reason- life cycle of Fasciola hepatica need to be appre- able deviations that can be made from these ciated. Fluke-infected cattle rarely demonstrate recommendations, and issues pertaining to the clinical disease, but subclinical impairment of economic impact of fluke infections in cattle, feed efficiency, growth, and fertility can have the complex life cycle of liver flukes (Figure 1) an important impact on productivity. Al- needs to be appreciated. though the precise benefit from controlling liv- Liver fluke transmission is dependent on the er flukes is unknown due to the inherent vari- presence of its snail intermediate host; there- ability between studies, most investigations fore, the distribution of the parasite is limited demonstrate a considerable economic advan- to geographic areas where the appropriate snail tage to treatment. In addition, recent studies species is present. In the US, liver flukes are en- have demonstrated that liver flukes may cause zootic primarily in the Gulf coast and western a decrease in host fertility by altering normal states, where high annual rainfall, large areas of metabolism and/or balance of sex hormones. -
A Literature Survey of Common Parasitic Zoonoses Encountered at Post-Mortem Examination in Slaughter Stocks in Tanzania: Economic and Public Health Implications
Volume 1- Issue 5 : 2017 DOI: 10.26717/BJSTR.2017.01.000419 Erick VG Komba. Biomed J Sci & Tech Res ISSN: 2574-1241 Research Article Open Access A Literature Survey of Common Parasitic Zoonoses Encountered at Post-Mortem Examination in Slaughter Stocks in Tanzania: Economic and Public Health Implications Erick VG Komba* Department of Veterinary Medicine and Public Health, Sokoine University of Agriculture, Tanzania Received: September 21, 2017; Published: October 06, 2017 *Corresponding author: Erick VG Komba, Senior lecturer, Department of Veterinary Medicine and Public Health, College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, P.O. Box 3021, Morogoro, Tanzania Abstract Zoonoses caused by parasites constitute a large group of infectious diseases with varying host ranges and patterns of transmission. Their public health impact of such zoonoses warrants appropriate surveillance to obtain enough information that will provide inputs in the design anddistribution, implementation prevalence of control and transmission strategies. Apatterns need therefore are affected arises by to the regularly influence re-evaluate of both human the current and environmental status of zoonotic factors. diseases, The economic particularly and in view of new data available as a result of surveillance activities and the application of new technologies. Consequently this paper summarizes available information in Tanzania on parasitic zoonoses encountered in slaughter stocks during post-mortem examination at slaughter facilities. The occurrence, in slaughter stocks, of fasciola spp, Echinococcus granulosus (hydatid) cysts, Taenia saginata Cysts, Taenia solium Cysts and ascaris spp. have been reported by various researchers. Information on these parasitic diseases is presented in this paper as they are the most important ones encountered in slaughter stocks in the country. -
The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca Volvulus Excretory Secretory Products
pathogens Review The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca volvulus Excretory Secretory Products Luc Vanhamme 1,*, Jacob Souopgui 1 , Stephen Ghogomu 2 and Ferdinand Ngale Njume 1,2 1 Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Université Libre de Bruxelles, Rue des Professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium; [email protected] (J.S.); [email protected] (F.N.N.) 2 Molecular and Cell Biology Laboratory, Biotechnology Unit, University of Buea, Buea P.O Box 63, Cameroon; [email protected] * Correspondence: [email protected] Received: 28 October 2020; Accepted: 18 November 2020; Published: 23 November 2020 Abstract: Nematodes constitute a very successful phylum, especially in terms of parasitism. Inside their mammalian hosts, parasitic nematodes mainly dwell in the digestive tract (geohelminths) or in the vascular system (filariae). One of their main characteristics is their long sojourn inside the body where they are accessible to the immune system. Several strategies are used by parasites in order to counteract the immune attacks. One of them is the expression of molecules interfering with the function of the immune system. Excretory-secretory products (ESPs) pertain to this category. This is, however, not their only biological function, as they seem also involved in other mechanisms such as pathogenicity or parasitic cycle (molting, for example). Wewill mainly focus on filariae ESPs with an emphasis on data available regarding Onchocerca volvulus, but we will also refer to a few relevant/illustrative examples related to other worm categories when necessary (geohelminth nematodes, trematodes or cestodes). -
In Vitro and in Vivo Trematode Models for Chemotherapeutic Studies
589 In vitro and in vivo trematode models for chemotherapeutic studies J. KEISER* Department of Medical Parasitology and Infection Biology, Swiss Tropical Institute, CH-4002 Basel, Switzerland (Received 27 June 2009; revised 7 August 2009 and 26 October 2009; accepted 27 October 2009; first published online 7 December 2009) SUMMARY Schistosomiasis and food-borne trematodiases are chronic parasitic diseases affecting millions of people mostly in the developing world. Additional drugs should be developed as only few drugs are available for treatment and drug resistance might emerge. In vitro and in vivo whole parasite screens represent essential components of the trematodicidal drug discovery cascade. This review describes the current state-of-the-art of in vitro and in vivo screening systems of the blood fluke Schistosoma mansoni, the liver fluke Fasciola hepatica and the intestinal fluke Echinostoma caproni. Examples of in vitro and in vivo evaluation of compounds for activity are presented. To boost the discovery pipeline for these diseases there is a need to develop validated, robust high-throughput in vitro systems with simple readouts. Key words: Schistosoma mansoni, Fasciola hepatica, Echinostoma caproni, in vitro, in vivo, drug discovery, chemotherapy. INTRODUCTION by chemotherapy. However, only two drugs are currently available: triclabendazole against fascio- Thus far approximately 6000 species in the sub-class liasis and praziquantel against the other food-borne Digenea, phylum Platyhelminthes have been de- trematode infections and schistosomiasis (Keiser and scribed in the literature. Among them, only a dozen Utzinger, 2004; Keiser et al. 2005). Hence, there is a or so species parasitize humans. These include need for discovery and development of new drugs, the blood flukes (five species of Schistosoma), liver particularly in view of growing concern about re- flukes (Clonorchis sinensis, Fasciola gigantica, Fasciola sistance developing to existing drugs. -
Federal Register/Vol. 85, No. 136/Wednesday, July 15, 2020
Federal Register / Vol. 85, No. 136 / Wednesday, July 15, 2020 / Notices 42883 interest to the IRS product DEPARTMENT OF HEALTH AND SUPPLEMENTARY INFORMATION: manufacturers who submitted timely HUMAN SERVICES Table of Contents exceptions, to determine whether the companies remained interested in Food and Drug Administration I. Background: Priority Review Voucher pursuing their appeals of the ALJ’s Program [Docket No. FDA–2008–N–0567] II. Diseases Being Designated Initial Decision. FDA informed the A. Opisthorchiasis companies that, if they did not respond Designating Additions to the Current B. Paragonimiasis and affirm their desire to pursue their List of Tropical Diseases in the Federal III. Process for Requesting Additional appeals by January 8, 2018, the Office of Food, Drug, and Cosmetic Act Diseases To Be Added to the List the Commissioner would conclude that IV. Paperwork Reduction Act AGENCY: Food and Drug Administration, V. References the companies no longer wish to pursue HHS. the appeal of the ALJ’s Initial Decision ACTION: Final order. I. Background: Priority Review and will proceed as if the appeals have Voucher Program been withdrawn. The Office of the SUMMARY: The Federal Food, Drug, and Section 524 of the FD&C Act (21 Commissioner did not receive a Cosmetic Act (FD&C Act) authorizes the U.S.C. 360n), which was added by response from any of the companies by Food and Drug Administration (FDA or section 1102 of the Food and Drug the given date; therefore, the Agency) to award priority review Administration Amendments Act of Commissioner now deems the vouchers (PRVs) to tropical disease 2007 (Pub. -
Fasciola Hepatica
Pathogens 2015, 4, 431-456; doi:10.3390/pathogens4030431 OPEN ACCESS pathogens ISSN 2076-0817 www.mdpi.com/journal/pathogens Review Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases Robert Hanna Section of Parasitology, Disease Surveillance and Investigation Branch, Veterinary Sciences Division, Agri-Food and Biosciences Institute, Stormont, Belfast BT4 3SD, UK; E-Mail: [email protected]; Tel.: +44-2890-525615 Academic Editor: Kris Chadee Received: 12 May 2015 / Accepted: 16 June 2015 / Published: 26 June 2015 Abstract: This review summarises the findings of a series of studies in which the histological changes, induced in the reproductive system of Fasciola hepatica following treatment of the ovine host with the anthelmintic triclabendazole (TCBZ), were examined. A detailed description of the normal macroscopic arrangement and histological features of the testes, ovary, vitelline tissue, Mehlis’ gland and uterus is provided to aid recognition of the drug-induced lesions, and to provide a basic model to inform similar toxicological studies on F. hepatica in the future. The production of spermatozoa and egg components represents the main energy consuming activity of the adult fluke. Thus the reproductive organs, with their high turnover of cells and secretory products, are uniquely sensitive to metabolic inhibition and sub-cellular disorganisation induced by extraneous toxic compounds. The flukes chosen for study were derived from TCBZ-sensitive (TCBZ-S) and TCBZ-resistant (TCBZ-R) isolates, the status of which had previously been proven in controlled clinical trials. For comparison, flukes collected from flocks where TCBZ resistance had been diagnosed by coprological methods, and from a dairy farm with no history of TCBZ use, were also examined. -
Parasitology Group Annual Review of Literature and Horizon Scanning Report 2018
APHA Parasitology Group Annual Review of Literature and Horizon Scanning Report 2018 Published: November 2019 November 2019 © Crown copyright 2018 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v.3. To view this licence visit www.nationalarchives.gov.uk/doc/open-government-licence/version/3/ or email [email protected] This publication is available at www.gov.uk/government/publications Any enquiries regarding this publication should be sent to us at [email protected] Year of publication: 2019 The Animal and Plant Health Agency (APHA) is an executive agency of the Department for Environment, Food & Rural Affairs, and also works on behalf of the Scottish Government and Welsh Government. November 2019 Contents Summary ............................................................................................................................. 1 Fasciola hepatica ............................................................................................................. 1 Rumen fluke (Calicophoron daubneyi) ............................................................................. 2 Parasitic gastro-enteritis (PGE) ........................................................................................ 2 Anthelmintic resistance .................................................................................................... 4 Cestodes ......................................................................................................................... -
Docket No. FDA-2008-N-0567]
This document is scheduled to be published in the Federal Register on 07/15/2020 and available online at federalregister.gov/d/2020-15253, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2008-N-0567] Notice of Decision Not to Designate Clonorchiasis as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA or Agency), in response to suggestions submitted to the public docket FDA-2008-N-0567, between June 20, 2018, and November 21, 2018, has analyzed whether the foodborne trematode infection clonorchiasis meets the statutory criteria for designation as a “tropical disease” for the purposes of obtaining a priority review voucher (PRV) under the Federal Food, Drug, and Cosmetic Act (FD&C Act), namely whether it primarily affects poor and marginalized populations and whether there is “no significant market” for drugs that prevent or treat clonorchiasis in developed countries. The Agency has determined at this time that clonorchiasis does not meet the statutory criteria for addition to the tropical diseases list under the FD&C Act. Although clonorchiasis disproportionately affects poor and marginalized populations, it is an infectious disease for which there is a significant market in developed nations; therefore, FDA declines to add it to the list of tropical diseases. DATES: [INSERT DATE OF PUBLICATION IN THE FEDERAL REGISTER]. ADDRESSES: Submit electronic comments on additional diseases suggested for designation to https://www.regulations.gov. -
WHO CC Web Fac.Farm V.Ingles
WHO COLLABORATING CENTRE ON FASCIOLIASIS AND ITS SNAIL VECTORS Reference of the World Health Organization (WHO/OMS): WHO CC SPA-37 Date of Nomination: 31 of March of 2011 Last update of the contents of this website: 28 of January of 2014 DESIGNATED CENTRE: Human Parasitic Disease Unit (Unidad de Parasitología Sanitaria) Departamento de Parasitología Facultad de Farmacia Universidad de Valencia Av. Vicent Andres Estelles s/n 46100 Burjassot - Valencia Spain DESIGNATED DIRECTOR OF THE CENTRE: Prof. Dr. Dr. Honoris Causa SANTIAGO MAS-COMA Parasitology Chairman WHO RESPONSIBLE OFFICER: Dr. DIRK ENGELS Coordinator, Preventive Chemotherapy and Transmission Control (HTM/NTD/PCT) (appointed as the new Director of the Department of Control of Neglected Tropical Diseases from 1 May 2014) Department of Control of Neglected Tropical Diseases (NTD) World Health Organization WHO Headquarters Avenue Appia No. 20 1211 Geneva 27 Switzerland RESEARCH GROUPS, LEADERS AND ACTIVITIES The Research Team designated as WHO CC comprises the following three Research Groups, Leaders and respective endorsed tasks: A) Research Group on (a) Epidemiology and (b) Control: Group Leader (research responsible): Prof. Dr. Dr. Honoris Causa SANTIAGO MAS-COMA Parasitology Chairman (Email: S. [email protected]) Activities: - Studies on the disease epidemiology in human fascioliasis endemic areas of Latin America, Europe, Africa and Asia - Implementation and follow up of disease control interventions against fascioliasis in human endemic areas B) Research Group on c) Transmission and d) Vectors: Group Leader (research responsible): Prof. Dra. MARIA DOLORES BARGUES Parasitology Chairwoman (Email: [email protected]) Activities: - Molecular, genetic and malacological characterization of lymnaeid snails - Studies on the transmission characteristics of human fascioliasis and the human infection ways in human fascioliasis endemic areas C) Research Group on e) Diagnostics and f) Immunopathology: Group Leader (research responsible): Prof. -
Diplomarbeit
DIPLOMARBEIT Titel der Diplomarbeit „Microscopic and molecular analyses on digenean trematodes in red deer (Cervus elaphus)“ Verfasserin Kerstin Liesinger angestrebter akademischer Grad Magistra der Naturwissenschaften (Mag.rer.nat.) Wien, 2011 Studienkennzahl lt. Studienblatt: A 442 Studienrichtung lt. Studienblatt: Diplomstudium Anthropologie Betreuerin / Betreuer: Univ.-Doz. Mag. Dr. Julia Walochnik Contents 1 ABBREVIATIONS ......................................................................................................................... 7 2 INTRODUCTION ........................................................................................................................... 9 2.1 History ..................................................................................................................................... 9 2.1.1 History of helminths ........................................................................................................ 9 2.1.2 History of trematodes .................................................................................................... 11 2.1.2.1 Fasciolidae ................................................................................................................. 12 2.1.2.2 Paramphistomidae ..................................................................................................... 13 2.1.2.3 Dicrocoeliidae ........................................................................................................... 14 2.1.3 Nomenclature ............................................................................................................... -
Common Helminth Infections of Donkeys and Their Control in Temperate Regions J
EQUINE VETERINARY EDUCATION / AE / SEPTEMBER 2013 461 Review Article Common helminth infections of donkeys and their control in temperate regions J. B. Matthews* and F. A. Burden† Disease Control, Moredun Research Institute, Edinburgh; and †The Donkey Sanctuary, Sidmouth, Devon, UK. *Corresponding author email: [email protected] Keywords: horse; donkey; helminths; anthelmintic resistance Summary management of helminths in donkeys is of general importance Roundworms and flatworms that affect donkeys can cause to their wellbeing and to that of co-grazing animals. disease. All common helminth parasites that affect horses also infect donkeys, so animals that co-graze can act as a source Nematodes that commonly affect donkeys of infection for either species. Of the gastrointestinal nematodes, those belonging to the cyathostomin (small Cyathostomins strongyle) group are the most problematic in UK donkeys. Most In donkey populations in which all animals are administered grazing animals are exposed to these parasites and some anthelmintics on a regular basis, most harbour low burdens of animals will be infected all of their lives. Control is threatened parasitic nematode infections and do not exhibit overt signs of by anthelmintic resistance: resistance to all 3 available disease. As in horses and ponies, the most common parasitic anthelmintic classes has now been recorded in UK donkeys. nematodes are the cyathostomin species. The life cycle of The lungworm, Dictyocaulus arnfieldi, is also problematical, these nematodes is the same as in other equids, with a period particularly when donkeys co-graze with horses. Mature of larval encystment in the large intestinal wall playing an horses are not permissive hosts to the full life cycle of this important role in the epidemiology and pathogenicity of parasite, but develop clinical signs on infection. -
Redalyc.Fasciola Hepatica: Epidemiology, Perspectives in The
Semina: Ciências Agrárias ISSN: 1676-546X [email protected] Universidade Estadual de Londrina Brasil Aleixo, Marcos André; França Freitas, Deivid; Hermes Dutra, Leonardo; Malone, John; Freire Martins, Isabella Vilhena; Beltrão Molento, Marcelo Fasciola hepatica: epidemiology, perspectives in the diagnostic and the use of geoprocessing systems for prevalence studie Semina: Ciências Agrárias, vol. 36, núm. 3, mayo-junio, 2015, pp. 1451-1465 Universidade Estadual de Londrina Londrina, Brasil Available in: http://www.redalyc.org/articulo.oa?id=445744148049 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative REVISÃO/REVIEW DOI: 10.5433/1679-0359.2015v36n3p1451 Fasciola hepatica : epidemiology, perspectives in the diagnostic and the use of geoprocessing systems for prevalence studies Fasciola hepatica : epidemiologia, perspectivas no diagnóstico e estudo de prevalência com uso de programas de geoprocessamento Marcos André Aleixo 1; Deivid França Freitas 2; Leonardo Hermes Dutra 1; John Malone 3; Isabella Vilhena Freire Martins 4; Marcelo Beltrão Molento 1, 5* Abstract Fasciola hepatica is a parasite that is located in the liver of ruminants with the possibility to infect horses, pigs and humans. The parasite belongs to the Trematoda class, and it is the agent causing the disease called fasciolosis. This disease occurs mainly in temperate regions where climate favors the development of the organism. These conditions must facilitate the development of the intermediate host, the snail of the genus Lymnaea . The infection in domestic animals can lead to decrease in production and control is made by using triclabendazole.